CSS LLC’s Acceleron Pharma XLRN Stock Holding History

CSS LLC’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,900	Closed	-$1.19M	–	1530
2021 Q3	$1.19M	Buy	+6,900	New	+$903K	0.05%	370
2020 Q4	–	Sell	-12,500	Closed	-$1.41M	–	1005
2020 Q3	$1.41M	Sell	12,500 -21,100	-63%	-$2.1M	0.07%	238
2020 Q2	$3.2M	Sell	33,600 -13,200	-28%	-$1.27M	0.18%	123
2020 Q1	$4.21M	Buy	+46,800	New	+$3.64M	0.33%	67

CSS LLC's XLRN Position: Q4 2020 in Review

CSS LLC sold out of Acceleron Pharma (XLRN) in Q4 2020, closing a stake of 3,000 shares — an estimated $338K sold.

CSS LLC first reported a position in XLRN in Q1 2020 and held it in 3 quarters. The position peaked at $929K in Q2 2020. 253 funds tracked by Wall St. Rank hold XLRN as of Q4 2020.

CSS LLC reported no remaining Acceleron Pharma position as of Q4 2020 after selling out during the quarter.
CSS LLC sold 3,000 Acceleron Pharma shares in Q4 2020, an estimated $338K.
CSS LLC first reported a position in Acceleron Pharma in Q1 2020 and held it in 3 quarters.
CSS LLC's Acceleron Pharma position peaked at $929K in Q2 2020.
253 funds tracked by Wall St. Rank held Acceleron Pharma as of Q4 2020.

Based on CSS LLC's 13F filing for Q4 2020, filed 16 Feb 2021.